EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

Ines Martinez-Corral iD, Nicholas Monaco iD, Daniel I Brierley iD, Monica Imbernon iD

British Journal of Pharmacology · 13.08.2026

DOI: 10.1111/bph.70636 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 13.08.2026. Verfasst von Ines Martinez-Corral und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, University …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Wellcome Trust, QMUL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance. Consequently, there is a renewed focus on how peripherally administered agents access the brain to exert these pharmacological effects. Circumventricular organs (CVOs) constitute specialised brain–blood interfaces that detect circulating metabolic, hormonal and inflammatory signals and relay them to neural circuits regulating cardiovascular function, reproduction and energy homeostasis. We recapitulate the organisation and physiological roles of CVOs, with particular emphasis on the median eminence and area postrema. These structures represent key sites of action for anti‐obesity drugs, gating the entry and signalling of GLP‐1 receptor agonists, and integrating information on energy status and inflammatory challenges. We discuss how dysregulation of these interfaces may contribute to obesity pathogenesis and how targeting CVO‐specific mechanisms may refine future pharmacotherapies.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1R agonistsarea postremablood–brain barriercircumventricular organsdrug deliverymedian eminenceneuroendocrine regulationobesitytanycytes

Autor:innen und Institutionen

  • Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, University of Lille, Lille, France.
  • Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
  • Blizard Institute, Centre for Immunobiology and Infection, Queen Mary University of London, London, UK.

ORCID-Profile: Ines Martinez-Corral, Nicholas Monaco, Daniel I Brierley, Monica Imbernon

Förderung

  • Agence Nationale de la Recherche
  • Wellcome Trust
  • QMUL
  • Queen Mary University of London

Zitieren

APA

Martinez-Corral, I., Monaco, N., Brierley, D. I., & Imbernon, M. (2026). Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation. British Journal of Pharmacology. https://doi.org/10.1111/bph.70636

Vancouver

Martinez-Corral I, Monaco N, Brierley DI, Imbernon M. Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation. British Journal of Pharmacology. 2026. doi:10.1111/bph.70636

BibTeX
@article{MartinezCorral2026,
  author = {Martinez-Corral, Ines and Monaco, Nicholas and Brierley, Daniel I and Imbernon, Monica},
  title = {Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70636}
}
Kostenlos starten →